RITA M HENRY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ONEIDA, NY NPI 1700622503
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$1,334.42
- Category: General Payments
- Program years: PY2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,334.42 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,238.43 | 50 |
| Education | $95.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $188.06 | 6 |
| Merck Sharp & Dohme Corporation | $120.14 | 5 |
| Astellas Pharma US Inc | $114.85 | 2 |
| E.R. Squibb & Sons, L.L.C. | $105.30 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $102.88 | 5 |
| EISAI INC. | $95.77 | 4 |
| Acerta Pharma LLC | $81.67 | 4 |
| Genmab U.S., Inc. | $50.41 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $48.68 | 2 |
| Incyte Corporation | $40.19 | 2 |
| Lilly USA, LLC | $38.10 | 2 |
| Blueprint Medicines Corporation | $36.03 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $30.86 | 2 |
| Geron Corporation | $30.61 | 1 |
| ABBVIE INC. | $26.19 | 1 |
| Daiichi Sankyo Inc. | $26.18 | 1 |
| ARRAY BIOPHARMA INC | $25.71 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.10 | 1 |
| Ipsen Biopharmaceuticals, Inc | $22.40 | 1 |
| Genentech USA, Inc. | $20.52 | 1 |
| Sumitomo Pharma America, Inc. | $19.28 | 1 |
| TAIHO ONCOLOGY, INC. | $18.56 | 1 |
| GlaxoSmithKline, LLC. | $18.42 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.60 | 1 |
| EMD Serono, Inc. | $17.06 | 1 |
| PFIZER INC. | $14.85 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $1,334.42 | 51 |
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.